Colorectal diffuse large B-cell lymphoma: molecular subclassification and prognostic significance of immunoglobulin gene translocation.
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
/ analysis
Colorectal Neoplasms
/ classification
Female
Genes, Immunoglobulin
Genetic Predisposition to Disease
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
Lymphoma, Large B-Cell, Diffuse
/ classification
Male
Middle Aged
Neoplasm Grading
Neoplasm Staging
Phenotype
Predictive Value of Tests
Progression-Free Survival
Proto-Oncogene Proteins c-bcl-2
/ genetics
Proto-Oncogene Proteins c-bcl-6
/ genetics
Proto-Oncogene Proteins c-myc
/ genetics
Retrospective Studies
Translocation, Genetic
Colon
Diffuse large B-cell lymphoma
Immunoglobulin
Prognosis
Rectum
Translocation
Journal
Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
21
05
2019
revised:
06
09
2019
accepted:
09
09
2019
pubmed:
18
11
2019
medline:
15
7
2020
entrez:
18
11
2019
Statut:
ppublish
Résumé
Primary colorectal diffuse large B-cell lymphoma (DLBCL) is rare, and its clinicopathological and genetic features are poorly understood. The aim of our study was to elucidate the frequency and prognostic significance of molecular subgroups in colorectal DLBCL. We examined 25 cases of colorectal lymphoma with DLBCL-like morphology and classified them into germinal center B-cell like (GCB)/non-GCB subgroups by immunohistochemistry (IHC) for CD10, bcl-6 and MUM1, or into double-expressor (DE)/non-DE subgroups by IHC for bcl-2 and c-myc. Translocations involving BCL2, BCL6, MYC, IGH, IGK, IGL, and MALT1 were also investigated using break-apart fluorescence in situ hybridization (FISH). The 25 cases were classified into two entities-DLBCL, not otherwise specified (NOS) (n = 23; 92%) and high grade B-cell lymphoma, double hit (n = 2; 8%)-according to the recent WHO classification. None of them showed histological evidence of Epstein-Barr virus infection or high-grade transformation from low grade B-cell lymphoma. Ten cases were GCB-type and four cases were DE-type, but these subtypes did not contribute to clinicopathological differences. Translocations involving BCL2, BCL6, MYC, IGH, IGK, IGL, and MALT1 were detected in 3 (12%), 3 (12%), 10 (40%), 14 (56%), 3 (12%), 3 (12%), and 0 (0%) of 25 cases, respectively. Of note, the presence of IGH translocation was significantly associated with better overall survival (P = .0053) and progression free survival (P = .0259). Similarly, the translocation involving at least one of the IGs (IGH, IGK, and/or IGL) was associated with more favorable prognosis in DLBCLs or even in DLBCL, NOS. This is the first report to reveal that a small subset of colorectal DLBCL corresponds to double-hit lymphoma. In addition, translocations involving at least one of the IGs may be a favorable prognostic factor in colorectal DLBCL. Testing the translocation involving rearrangement of IGs as well as MYC and BCL2/BCL6 may thus be useful for diagnosis and prognosis.
Identifiants
pubmed: 31734190
pii: S0046-8177(19)30168-6
doi: 10.1016/j.humpath.2019.09.003
pii:
doi:
Substances chimiques
BCL2 protein, human
0
BCL6 protein, human
0
Biomarkers, Tumor
0
MYC protein, human
0
Proto-Oncogene Proteins c-bcl-2
0
Proto-Oncogene Proteins c-bcl-6
0
Proto-Oncogene Proteins c-myc
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
67-78Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.